Edson R. Da Silva
Pirassununga, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Comprehensive kinase inhibitor screening reveals potential therapeutic targets in canine melanoma: A Comparative Precision Oncology study.
Journal: Research in veterinary science
Published: November 16, 2025
Caffeic Acid Phenethyl Ester (CAPE) Inhibits Arginase Activity and Growth of Leishmania amazonensis Promastigotes and Intracellular Amastigotes.
Journal: Pathogens (Basel, Switzerland)
Published: December 17, 2024
Design and Synthesis of New Anthranyl Phenylhydrazides: Antileishmanial Activity and Structure-Activity Relationship.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 29, 2023
In Vitro and In Silico Analyses of New Cinnamid and Rosmarinic Acid-Derived Compounds Biosynthesized in Escherichia coli as Leishmania amazonensis Arginase Inhibitors.
Journal: Pathogens (Basel, Switzerland)
Published: August 10, 2022
Cinnamides Target Leishmania amazonensis Arginase Selectively.
Journal: Molecules (Basel, Switzerland)
Published: October 16, 2020
Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase.
Journal: Chemical biology & drug design
Published: May 25, 2018
Antileishmanial activity of verbascoside: Selective arginase inhibition of intracellular amastigotes of Leishmania (Leishmania) amazonensis with resistance induced by LPS plus IFN-γ.
Journal: Biochemical pharmacology
Published: October 14, 2016
Novel selective inhibitor of Leishmania (Leishmania) amazonensis arginase.
Journal: Chemical biology & drug design
Published: October 23, 2014
Dietary flavonoids fisetin, luteolin and their derived compounds inhibit arginase, a central enzyme in Leishmania (Leishmania) amazonensis infection.
Journal: Food chemistry
Published: October 26, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026